Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen

[1]  T. Hökfelt,et al.  Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing β-amyloid precursor protein (APP) with the Swedish double mutation (APP23) , 2003, Neurobiology of Disease.

[2]  Robert Lalonde,et al.  Transgenic mice expressing the βAPP 695SWE mutation: effects on exploratory activity, anxiety, and motor coordination , 2003, Brain Research.

[3]  M. Staufenbiel,et al.  Regional brain cytochrome oxidase activity in β-amyloid precursor protein transgenic mice with the swedish mutation , 2003, Neuroscience.

[4]  Robert Lalonde,et al.  Characterization of NFH-LacZ transgenic mice with the SHIRPA primary screening battery and tests of motor coordination, exploratory activity, and spatial learning , 2003, Behavioural Processes.

[5]  P. Kelly,et al.  Progressive age-related impairment of cognitive behavior in APP23 transgenic mice , 2003, Neurobiology of Aging.

[6]  S. Qian,et al.  Transgenic mice expressing the PS1-A246E mutation: effects on spatial learning, exploration, anxiety, and motor coordination , 2003, Behavioural Brain Research.

[7]  R. D'Hooge,et al.  Age‐dependent cognitive decline in the APP23 model precedes amyloid deposition , 2003, The European journal of neuroscience.

[8]  M. Staufenbiel,et al.  Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation , 2002, Brain Research.

[9]  Markus Rudin,et al.  Compromised Hemodynamic Response in Amyloid Precursor Protein Transgenic Mice , 2002, The Journal of Neuroscience.

[10]  P. Kelly,et al.  Cholinergic Changes in the APP23 Transgenic Mouse Model of Cerebral Amyloidosis , 2002, The Journal of Neuroscience.

[11]  M. Staufenbiel,et al.  Amyloid-Associated Neuron Loss and Gliogenesis in the Neocortex of Amyloid Precursor Protein Transgenic Mice , 2002, The Journal of Neuroscience.

[12]  J. Hagan,et al.  Development of SHIRPA to characterise the phenotype of gene-targeted mice , 2001, Behavioural Brain Research.

[13]  A. V. Anagnostopoulos,et al.  Transgenic and knockout databases Behavioral profiles of mouse mutants , 2001, Physiology & Behavior.

[14]  David Surjo,et al.  The Mutant Mouse Behaviour network A medium to present and discuss methods for the behavioural phenotyping , 2001, Physiology & Behavior.

[15]  M. Farmer,et al.  Trans-NIH neuroscience initiatives on mouse phenotyping and mutagenesis , 2001, Mammalian Genome.

[16]  E. Fisher,et al.  SHIRPA, a protocol for behavioral assessment: validation for longitudinal study of neurological dysfunction in mice , 2001, Neuroscience Letters.

[17]  M. Staufenbiel,et al.  Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains* , 2001, The Journal of Biological Chemistry.

[18]  Y. Iwakura,et al.  Involvement of EphA2 in the formation of the tail notochord via interaction with ephrinA1 , 2001, Mechanisms of Development.

[19]  M. Staufenbiel,et al.  Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy , 2001, The Journal of Neuroscience.

[20]  K. Davies,et al.  Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmdmdx and Dmdmdx3cv dystrophin-deficient mice , 2000, Mammalian Genome.

[21]  C. Broeckhoven,et al.  Behavioral Disturbances without Amyloid Deposits in Mice Overexpressing Human Amyloid Precursor Protein with Flemish (A692G) or Dutch (E693Q) Mutation , 2000, Neurobiology of Disease.

[22]  Jim J. Hagan,et al.  Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains , 1999, Behavioural Brain Research.

[23]  J. Turner,et al.  Prolonged exposure to an augmented acoustic environment ameliorates age-related auditory changes in C57BL/6J and DBA/2J mice , 1999, Hearing Research.

[24]  B. Sommer,et al.  Association of microglia with amyloid plaques in brains of APP23 transgenic mice. , 1999, The American journal of pathology.

[25]  Veerle Baekelandt,et al.  Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain* , 1999, The Journal of Biological Chemistry.

[26]  B. Sommer,et al.  Neuron loss in APP transgenic mice , 1998, Nature.

[27]  C. Goetz,et al.  5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes. , 1998, European journal of pharmacology.

[28]  B. Sommer,et al.  Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  E. Fisher,et al.  Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment , 1997, Mammalian Genome.

[30]  F. Lestienne,et al.  Neurobehavioral evaluation of lurcher mutant mice during ontogeny. , 1997, Brain research. Developmental brain research.

[31]  Y. Agid,et al.  A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years. , 1996, Neuroreport.

[32]  D. Borchelt,et al.  Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins , 1995, Neuron.

[33]  M. Dickinson,et al.  Molecular and phenotypic characterization of a new mouse insertional mutation that causes a defect in the distal vertebrae of the spine. , 1995, Genetics.

[34]  J. Caston,et al.  Differential roles of cerebellar cortex and deep cerebellar nuclei in the learning of the equilibrium behavior: studies in intact and cerebellectomized lurcher mutant mice. , 1995, Brain research. Developmental brain research.

[35]  R. Levy,et al.  Neurologic signs in Alzheimer's disease. Results of a prospective clinical and neuropathologic study. , 1992, Archives of neurology.

[36]  R. Mayeux,et al.  Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. , 1991, Archives of neurology.

[37]  F. Boller,et al.  The neurologic examination in patients with probable Alzheimer's disease. , 1987, Archives of neurology.

[38]  Robert Lalonde,et al.  Chapter 4.3 Motor performance of spontaneous murine mutations with cerebellar atrophy , 1999 .

[39]  Wim E Crusio,et al.  Handbook of molecular-genetic techniques for brain and behavior research , 1999 .

[40]  C. Bieberich,et al.  The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice , 1995, Nature Genetics.